These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 36777277)

  • 21. Rates and Predictors of Vaccinations Among Inflammatory Bowel Disease Patients Receiving Anti-Tumor Necrosis Factor Agents.
    Pham HV; Hasan I; Udaltsova N; Pham K; Abramson O; Armstrong MA; Postlethwaite D; Li D
    Dig Dis Sci; 2018 Jan; 63(1):209-217. PubMed ID: 28836068
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety of Immunizations for the Adult Patient With Inflammatory Bowel Disease-A Systematic Review and Meta-analysis.
    Desalermos A; Pimienta M; Kalligeros M; Shehadeh F; Diamantopoulos L; Karamanolis G; Caldera F; Farraye FA
    Inflamm Bowel Dis; 2022 Sep; 28(9):1430-1442. PubMed ID: 34849941
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influenza and Pneumococcal Vaccination Rates in Patients With Inflammatory Bowel Disease.
    Reich JS; Miller HL; Wasan SK; Noronha A; Ardagna E; Sullivan K; Jacobson B; Farraye FA
    Gastroenterol Hepatol (N Y); 2015 Jun; 11(6):396-401. PubMed ID: 27118933
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunogenicity and mechanisms impairing the response to vaccines in inflammatory bowel disease.
    Marín AC; Gisbert JP; Chaparro M
    World J Gastroenterol; 2015 Oct; 21(40):11273-81. PubMed ID: 26527572
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunogenecity of hepatitis A and B vaccination in pediatric patients with inflammatory bowel disease.
    Urganci N; Kalyoncu D
    J Pediatr Gastroenterol Nutr; 2013 Apr; 56(4):412-15. PubMed ID: 23841120
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Can we better protect patients with inflammatory bowel disease against infections - patient attitude and personal immunization knowledge.
    Waszczuk K; Waszczuk E; Szenborn L
    Acta Gastroenterol Belg; 2018; 81(2):257-261. PubMed ID: 30024696
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vaccinating Patients With Inflammatory Bowel Disease.
    Reich J; Wasan S; Farraye FA
    Gastroenterol Hepatol (N Y); 2016 Sep; 12(9):540-546. PubMed ID: 27917091
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suboptimal Vaccination Administration in Mothers With Inflammatory Bowel Disease and Their Biologic-Exposed Infants.
    Chiarella-Redfern H; Lee S; Jubran B; Sharifi N; Panaccione R; Constantinescu C; Benchimol EI; Seow CH
    Inflamm Bowel Dis; 2022 Jan; 28(1):79-86. PubMed ID: 33609034
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship between patient copayments in Medicare Part D and vaccination claim status for herpes zoster and tetanus-diphtheria-acellular pertussis.
    Yan S; DerSarkissian M; Bhak RH; Lefebvre P; Duh MS; Krishnarajah G
    Curr Med Res Opin; 2018 Jul; 34(7):1261-1269. PubMed ID: 29231748
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Compliance with the guidelines on recommended immunization schedule in patients with inflammatory bowel disease: implications on public health policies.
    García-Serrano C; Mirada G; Marsal JR; Ortega M; Sol J; Solano R; Artigues EM; Estany P
    BMC Public Health; 2020 May; 20(1):713. PubMed ID: 32429900
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vaccinations and inflammatory bowel disease - a systematic review.
    Chan W; Salazar E; Lim TG; Ong WC; Shim HH
    Dig Liver Dis; 2021 Sep; 53(9):1079-1088. PubMed ID: 33994128
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influenza, PCV13, and PPSV23 Vaccination Rates Among Inflammatory Bowel Disease Patients With Additional Co-Morbidities as per CDC Recommendations.
    Jordan A; Mills K; Sobukonla T; Kelly A; Flood M
    Cureus; 2021 Sep; 13(9):e18387. PubMed ID: 34729268
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of Live Attenuated Herpes Zoster Vaccine in Patients With Inflammatory Bowel Diseases.
    Khan N; Trivedi C; Kavani H; Medvedeva E; Lewis J; Yang YX
    Clin Gastroenterol Hepatol; 2019 Jun; 17(7):1341-1347. PubMed ID: 30326303
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of a multi-modal intervention on immunization rates in obstetrics and gynecology clinics.
    Mazzoni SE; Brewer SE; Pyrzanowski JL; Durfee MJ; Dickinson LM; Barnard JG; Dempsey AF; O'Leary ST
    Am J Obstet Gynecol; 2016 May; 214(5):617.e1-7. PubMed ID: 26627727
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of Education and Information on Vaccination Behavior in Patients with Inflammatory Bowel Disease.
    Coenen S; Weyts E; Jorissen C; De Munter P; Noman M; Ballet V; Vermeire S; Van Assche G; Ferrante M
    Inflamm Bowel Dis; 2017 Feb; 23(2):318-324. PubMed ID: 28079621
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lower Sustained Diphtheria and Pertussis Antibody Concentrations in Inflammatory Bowel Disease Patients.
    Caldera F; Saha S; Wald A; Garmoe CA; McCrone S; Megna B; Ley D; Reichelderfer M; Hayney MS
    Dig Dis Sci; 2018 Jun; 63(6):1532-1540. PubMed ID: 29594970
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of immunosuppressive therapy on hepatitis B vaccination in inflammatory bowel diseases.
    Belle A; Baumann C; Bigard MA; Zallot C; Gizard E; Guéant JL; Bronowicki JP; Peyrin-Biroulet L
    Eur J Gastroenterol Hepatol; 2015 Aug; 27(8):877-81. PubMed ID: 26121376
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunization history of children with inflammatory bowel disease.
    Soon IS; deBruyn JC; Wrobel I
    Can J Gastroenterol; 2013 Apr; 27(4):213-6. PubMed ID: 23616959
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vaccination and Risk for Developing Inflammatory Bowel Disease: A Meta-Analysis of Case-Control and Cohort Studies.
    Pineton de Chambrun G; Dauchet L; Gower-Rousseau C; Cortot A; Colombel JF; Peyrin-Biroulet L
    Clin Gastroenterol Hepatol; 2015 Aug; 13(8):1405-15.e1; quiz e130. PubMed ID: 25956840
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Maternal pertussis vaccination and its effects on the immune response of infants aged up to 12 months in the Netherlands: an open-label, parallel, randomised controlled trial.
    Barug D; Pronk I; van Houten MA; Versteegh FGA; Knol MJ; van de Kassteele J; Berbers GAM; Sanders EAM; Rots NY
    Lancet Infect Dis; 2019 Apr; 19(4):392-401. PubMed ID: 30938299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.